SCHEMBL29665672

SCHEMBL29665672

NCCn1nc(-c2ccc(Oc3ccccc3)cc2)c2c(N)ncnc21

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 14/20 0.72
NUDT14 O95848 2/20 0.71
NUDT5 Q9UKK9 2/20 0.71
LCK P06239 6/20 0.66
ITK Q08881 3/20 0.66
EGFR P00533 2/20 0.66
JAK3 P52333 2/20 0.66
SRC P12931 7/20 0.62
LYN P07948 5/20 0.61
FYN P06241 5/20 0.61
FLT3 P36888 4/20 0.61
PTK6 Q13882 4/20 0.61
HCK P08631 3/20 0.61
FGR P09769 3/20 0.61
MAP2K1 Q02750 3/20 0.61
BRAF P15056 3/20 0.61
BMX P51813 3/20 0.61
YES1 P07947 2/20 0.61
BLK P51451 2/20 0.61
MAP2K5 Q13163 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13861437 1.00 BTK (0.72) BTKNUDT14NUDT5LCKITK
Hydrochloric Acid SCHEMBL29665759 0.99 BTK (0.70) BTKNUDT14NUDT5LCKITK
SCHEMBL24458025 0.93 BTK (0.69) BTKNUDT14NUDT5LCKITK
SCHEMBL16448087 0.90 BTK (0.70) BTKNUDT14NUDT5LCKITK
SCHEMBL15916593 0.88 BTK (0.67) BTKNUDT14NUDT5LCKITK
SCHEMBL27019885 0.87 PIK3CD (0.72) BTKNUDT14NUDT5LCKITK
SCHEMBL22909341 0.87 NUDT14 (0.72) BTKNUDT14NUDT5LCKITK
SCHEMBL28407363 0.86 BTK (0.89) BTKNUDT14NUDT5LCKITK
SCHEMBL23409030 0.85 NUDT14 (0.66) BTKNUDT14NUDT5LCKITK
SCHEMBL16448039 0.85 BTK (0.64) BTKNUDT14NUDT5LCKITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024175999-A2 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF DUNAD THERAPEUTICS LTD. (GB) 2024-08-29 WO disclosed
US-20240018153-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 ONTARIO, INC. (CA) 2024-01-18 US disclosed
EP-4247794-A2 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 Ontario, Inc. (CA) 2023-09-27 EP disclosed
WO-2022106902-A2 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 ONTARIO, INC. (CA) 2022-05-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018153-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF ABCG2, ABCB1, ARSA BTK 55/4885NUDT14 1332/4885NUDT5 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.